Yao-tseng Chen

USPTO Granted Patents = 42 (Patent Applications = 1)

EPO Patents = 1

Average Co-Inventor Count = 5.9

ph-index = 9

Forward Citations = 348(Granted Patents)

Company Filing History:

28 out of 525

Ludwig Institute for Cancer Research Limited

patents

12 out of 1,521

Cornell Research Foundation Inc.

patents

11 out of 559

Memorial Sloan Kettering Cancer Center

patents

4. 2 out of 2

The New York Hospital-cornell Medical Center

patents

5. 1 out of 3

Ludwig Institute of Cancer Research

patents

6. 12 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2013

Loading Chart...

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8541202 - Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein (2013-09-24),

2. 8142786 - Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein (2012-03-27),

3. 8071717 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof (2011-12-06),

4. 7888100 - Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein (2011-02-15),

5. 7795409 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof (2010-09-14),

6. 7354992 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof (2008-04-08),

7. 7335467 - Breast cancer antigens (2008-02-26),

8. 7314721 - Small cell lung cancer associated antigens and uses therefor (2008-01-01),

9. 7291335 - Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof (2007-11-06),

10. 7132507 - Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses (2006-11-07),

11. 7115729 - Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 (2006-10-03),

12. 7009035 - Isolated peptides which bind to HLA-C molecules and uses thereof (2006-03-07),

13. 6982316 - Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer (2006-01-03),

14. 6911529 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof (2005-06-28),

15. 6830924 - Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof (2004-12-14),

Title: The Inventive Journey of Yao-tseng Chen: Pioneering Peptides and Therapeutics in New York

Introduction: Meet Yao-tseng Chen, a prolific inventor based in New York, NY, with an impressive portfolio of 42 patents. His groundbreaking work has significantly impacted the fields of immunotherapy and cancer research.

Latest Patents: One of Yao-tseng Chen's latest patents is the "Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein." This innovative method involves utilizing peptides that bind to MHC Class I and MHC Class II molecules, showcasing their utility in various therapeutic and diagnostic applications.

Career Highlights: Yao-tseng Chen has made significant contributions to the field through his work at distinguished institutions such as the Ludwig Institute for Cancer Research Limited and Cornell Research Foundation Inc. His expertise and dedication have led to the development of cutting-edge technologies that have the potential to transform healthcare practices.

Collaborations: Throughout his career, Yao-tseng Chen has collaborated with esteemed professionals, including Lloyd J. Old and Matthew J. Scanlan. These collaborative efforts have fostered innovation and driven forward the boundaries of scientific research in the ever-evolving landscape of medical advancements.

Conclusion: In conclusion, Yao-tseng Chen stands as a beacon of innovation in the realm of medical research, continuously pushing the boundaries of what is possible in the field of immunotherapy and cancer treatment. His remarkable contributions serve as a testament to his commitment to scientific excellence and his enduring legacy in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.